Table of Content

1 Gefitinib Tablets Market Overview
1.1 Product Overview and Scope of Gefitinib Tablets
1.2 Gefitinib Tablets Segment by Type
1.2.1 Global Gefitinib Tablets Market Value Comparison by Type (2024-2034)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Gefitinib Tablets Segment by Application
1.3.1 Global Gefitinib Tablets Market Value by Application: (2024-2034)
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Other
1.4 Global Gefitinib Tablets Market Size Estimates and Forecasts
1.4.1 Global Gefitinib Tablets Revenue 2018-2034
1.4.2 Global Gefitinib Tablets Sales 2018-2034
1.4.3 Global Gefitinib Tablets Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Gefitinib Tablets Market Competition by Manufacturers
2.1 Global Gefitinib Tablets Sales Market Share by Manufacturers (2018-2024)
2.2 Global Gefitinib Tablets Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Gefitinib Tablets Average Price by Manufacturers (2018-2024)
2.4 Global Gefitinib Tablets Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Gefitinib Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gefitinib Tablets, Product Type & Application
2.7 Gefitinib Tablets Market Competitive Situation and Trends
2.7.1 Gefitinib Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gefitinib Tablets Players Market Share by Revenue
2.7.3 Global Gefitinib Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gefitinib Tablets Retrospective Market Scenario by Region
3.1 Global Gefitinib Tablets Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Gefitinib Tablets Global Gefitinib Tablets Sales by Region: 2018-2034
3.2.1 Global Gefitinib Tablets Sales by Region: 2018-2024
3.2.2 Global Gefitinib Tablets Sales by Region: 2024-2034
3.3 Global Gefitinib Tablets Global Gefitinib Tablets Revenue by Region: 2018-2034
3.3.1 Global Gefitinib Tablets Revenue by Region: 2018-2024
3.3.2 Global Gefitinib Tablets Revenue by Region: 2024-2034
3.4 North America Gefitinib Tablets Market Facts & Figures by Country
3.4.1 North America Gefitinib Tablets Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Gefitinib Tablets Sales by Country (2018-2034)
3.4.3 North America Gefitinib Tablets Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gefitinib Tablets Market Facts & Figures by Country
3.5.1 Europe Gefitinib Tablets Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Gefitinib Tablets Sales by Country (2018-2034)
3.5.3 Europe Gefitinib Tablets Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gefitinib Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Gefitinib Tablets Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Gefitinib Tablets Sales by Country (2018-2034)
3.6.3 Asia Pacific Gefitinib Tablets Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gefitinib Tablets Market Facts & Figures by Country
3.7.1 Latin America Gefitinib Tablets Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Gefitinib Tablets Sales by Country (2018-2034)
3.7.3 Latin America Gefitinib Tablets Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Gefitinib Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Gefitinib Tablets Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Gefitinib Tablets Sales by Country (2018-2034)
3.8.3 Middle East and Africa Gefitinib Tablets Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gefitinib Tablets Sales by Type (2018-2034)
4.1.1 Global Gefitinib Tablets Sales by Type (2018-2024)
4.1.2 Global Gefitinib Tablets Sales by Type (2024-2034)
4.1.3 Global Gefitinib Tablets Sales Market Share by Type (2018-2034)
4.2 Global Gefitinib Tablets Revenue by Type (2018-2034)
4.2.1 Global Gefitinib Tablets Revenue by Type (2018-2024)
4.2.2 Global Gefitinib Tablets Revenue by Type (2024-2034)
4.2.3 Global Gefitinib Tablets Revenue Market Share by Type (2018-2034)
4.3 Global Gefitinib Tablets Price by Type (2018-2034)
5 Segment by Application
5.1 Global Gefitinib Tablets Sales by Application (2018-2034)
5.1.1 Global Gefitinib Tablets Sales by Application (2018-2024)
5.1.2 Global Gefitinib Tablets Sales by Application (2024-2034)
5.1.3 Global Gefitinib Tablets Sales Market Share by Application (2018-2034)
5.2 Global Gefitinib Tablets Revenue by Application (2018-2034)
5.2.1 Global Gefitinib Tablets Revenue by Application (2018-2024)
5.2.2 Global Gefitinib Tablets Revenue by Application (2024-2034)
5.2.3 Global Gefitinib Tablets Revenue Market Share by Application (2018-2034)
5.3 Global Gefitinib Tablets Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Qilu Pharmaceutical
6.1.1 Qilu Pharmaceutical Corporation Information
6.1.2 Qilu Pharmaceutical Description and Business Overview
6.1.3 Qilu Pharmaceutical Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Qilu Pharmaceutical Gefitinib Tablets Product Portfolio
6.1.5 Qilu Pharmaceutical Recent Developments/Updates
6.2 Sichuan Kelun Pharmaceutical Co.,Ltd.
6.2.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Corporation Information
6.2.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product Portfolio
6.2.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product Portfolio
6.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
6.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Corporation Information
6.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolio
6.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product Portfolio
6.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.6 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
6.6.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolio
6.6.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
6.6.1 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Corporation Information
6.6.2 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Description and Business Overview
6.6.3 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product Portfolio
6.7.5 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Recent Developments/Updates
6.8 NatcoPharma
6.8.1 NatcoPharma Corporation Information
6.8.2 NatcoPharma Description and Business Overview
6.8.3 NatcoPharma Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.8.4 NatcoPharma Gefitinib Tablets Product Portfolio
6.8.5 NatcoPharma Recent Developments/Updates
6.9 AstraZeneca plc
6.9.1 AstraZeneca plc Corporation Information
6.9.2 AstraZeneca plc Description and Business Overview
6.9.3 AstraZeneca plc Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.9.4 AstraZeneca plc Gefitinib Tablets Product Portfolio
6.9.5 AstraZeneca plc Recent Developments/Updates
6.10 Intelicure Lifesciences
6.10.1 Intelicure Lifesciences Corporation Information
6.10.2 Intelicure Lifesciences Description and Business Overview
6.10.3 Intelicure Lifesciences Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Intelicure Lifesciences Gefitinib Tablets Product Portfolio
6.10.5 Intelicure Lifesciences Recent Developments/Updates
6.11 Weefsel Pharma
6.11.1 Weefsel Pharma Corporation Information
6.11.2 Weefsel Pharma Gefitinib Tablets Description and Business Overview
6.11.3 Weefsel Pharma Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Weefsel Pharma Gefitinib Tablets Product Portfolio
6.11.5 Weefsel Pharma Recent Developments/Updates
6.12 Taj Pharmaceuticals
6.12.1 Taj Pharmaceuticals Corporation Information
6.12.2 Taj Pharmaceuticals Gefitinib Tablets Description and Business Overview
6.12.3 Taj Pharmaceuticals Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Taj Pharmaceuticals Gefitinib Tablets Product Portfolio
6.12.5 Taj Pharmaceuticals Recent Developments/Updates
6.13 Saintroy Lifescience
6.13.1 Saintroy Lifescience Corporation Information
6.13.2 Saintroy Lifescience Gefitinib Tablets Description and Business Overview
6.13.3 Saintroy Lifescience Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Saintroy Lifescience Gefitinib Tablets Product Portfolio
6.13.5 Saintroy Lifescience Recent Developments/Updates
6.14 Actiza Pharmaceutical
6.14.1 Actiza Pharmaceutical Corporation Information
6.14.2 Actiza Pharmaceutical Gefitinib Tablets Description and Business Overview
6.14.3 Actiza Pharmaceutical Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Actiza Pharmaceutical Gefitinib Tablets Product Portfolio
6.14.5 Actiza Pharmaceutical Recent Developments/Updates
6.15 Teva
6.15.1 Teva Corporation Information
6.15.2 Teva Gefitinib Tablets Description and Business Overview
6.15.3 Teva Gefitinib Tablets Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Teva Gefitinib Tablets Product Portfolio
6.15.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gefitinib Tablets Industry Chain Analysis
7.2 Gefitinib Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gefitinib Tablets Production Mode & Process
7.4 Gefitinib Tablets Sales and Marketing
7.4.1 Gefitinib Tablets Sales Channels
7.4.2 Gefitinib Tablets Distributors
7.5 Gefitinib Tablets Customers
8 Gefitinib Tablets Market Dynamics
8.1 Gefitinib Tablets Industry Trends
8.2 Gefitinib Tablets Market Drivers
8.3 Gefitinib Tablets Market Challenges
8.4 Gefitinib Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Gefitinib Tablets Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Gefitinib Tablets Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Gefitinib Tablets Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gefitinib Tablets Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Gefitinib Tablets Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Gefitinib Tablets Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Gefitinib Tablets Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Gefitinib Tablets Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Gefitinib Tablets, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Gefitinib Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gefitinib Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Gefitinib Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gefitinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gefitinib Tablets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gefitinib Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Gefitinib Tablets Sales by Region (2018-2024) & (K Units)
Table 18. Global Gefitinib Tablets Sales Market Share by Region (2018-2024)
Table 19. Global Gefitinib Tablets Sales by Region (2024-2034) & (K Units)
Table 20. Global Gefitinib Tablets Sales Market Share by Region (2024-2034)
Table 21. Global Gefitinib Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Gefitinib Tablets Revenue Market Share by Region (2018-2024)
Table 23. Global Gefitinib Tablets Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Gefitinib Tablets Revenue Market Share by Region (2024-2034)
Table 25. North America Gefitinib Tablets Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 27. North America Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 28. North America Gefitinib Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Gefitinib Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Gefitinib Tablets Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 32. Europe Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 33. Europe Gefitinib Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Gefitinib Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Gefitinib Tablets Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Gefitinib Tablets Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Gefitinib Tablets Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Gefitinib Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Gefitinib Tablets Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Gefitinib Tablets Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Gefitinib Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Gefitinib Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Gefitinib Tablets Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Gefitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Gefitinib Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Gefitinib Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Gefitinib Tablets Sales (K Units) by Type (2018-2024)
Table 51. Global Gefitinib Tablets Sales (K Units) by Type (2024-2034)
Table 52. Global Gefitinib Tablets Sales Market Share by Type (2018-2024)
Table 53. Global Gefitinib Tablets Sales Market Share by Type (2024-2034)
Table 54. Global Gefitinib Tablets Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Gefitinib Tablets Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Gefitinib Tablets Revenue Market Share by Type (2018-2024)
Table 57. Global Gefitinib Tablets Revenue Market Share by Type (2024-2034)
Table 58. Global Gefitinib Tablets Price (US$/Unit) by Type (2018-2024)
Table 59. Global Gefitinib Tablets Price (US$/Unit) by Type (2024-2034)
Table 60. Global Gefitinib Tablets Sales (K Units) by Application (2018-2024)
Table 61. Global Gefitinib Tablets Sales (K Units) by Application (2024-2034)
Table 62. Global Gefitinib Tablets Sales Market Share by Application (2018-2024)
Table 63. Global Gefitinib Tablets Sales Market Share by Application (2024-2034)
Table 64. Global Gefitinib Tablets Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Gefitinib Tablets Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Gefitinib Tablets Revenue Market Share by Application (2018-2024)
Table 67. Global Gefitinib Tablets Revenue Market Share by Application (2024-2034)
Table 68. Global Gefitinib Tablets Price (US$/Unit) by Application (2018-2024)
Table 69. Global Gefitinib Tablets Price (US$/Unit) by Application (2024-2034)
Table 70. Qilu Pharmaceutical Corporation Information
Table 71. Qilu Pharmaceutical Description and Business Overview
Table 72. Qilu Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Qilu Pharmaceutical Gefitinib Tablets Product
Table 74. Qilu Pharmaceutical Recent Developments/Updates
Table 75. Sichuan Kelun Pharmaceutical Co.,Ltd. Corporation Information
Table 76. Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
Table 77. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product
Table 79. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 80. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
Table 81. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
Table 85. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Corporation Information
Table 86. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product
Table 89. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 91. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 92. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product
Table 94. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 95. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Corporation Information
Table 96. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product
Table 99. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Corporation Information
Table 101. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Description and Business Overview
Table 102. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product
Table 104. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Recent Developments/Updates
Table 105. NatcoPharma Corporation Information
Table 106. NatcoPharma Description and Business Overview
Table 107. NatcoPharma Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. NatcoPharma Gefitinib Tablets Product
Table 109. NatcoPharma Recent Developments/Updates
Table 110. AstraZeneca plc Corporation Information
Table 111. AstraZeneca plc Description and Business Overview
Table 112. AstraZeneca plc Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. AstraZeneca plc Gefitinib Tablets Product
Table 114. AstraZeneca plc Recent Developments/Updates
Table 115. Intelicure Lifesciences Corporation Information
Table 116. Intelicure Lifesciences Description and Business Overview
Table 117. Intelicure Lifesciences Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Intelicure Lifesciences Gefitinib Tablets Product
Table 119. Intelicure Lifesciences Recent Developments/Updates
Table 120. Weefsel Pharma Corporation Information
Table 121. Weefsel Pharma Description and Business Overview
Table 122. Weefsel Pharma Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Weefsel Pharma Gefitinib Tablets Product
Table 124. Weefsel Pharma Recent Developments/Updates
Table 125. Taj Pharmaceuticals Corporation Information
Table 126. Taj Pharmaceuticals Description and Business Overview
Table 127. Taj Pharmaceuticals Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Taj Pharmaceuticals Gefitinib Tablets Product
Table 129. Taj Pharmaceuticals Recent Developments/Updates
Table 130. Saintroy Lifescience Corporation Information
Table 131. Saintroy Lifescience Description and Business Overview
Table 132. Saintroy Lifescience Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Saintroy Lifescience Gefitinib Tablets Product
Table 134. Saintroy Lifescience Recent Developments/Updates
Table 135. Actiza Pharmaceutical Corporation Information
Table 136. Actiza Pharmaceutical Description and Business Overview
Table 137. Actiza Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Actiza Pharmaceutical Gefitinib Tablets Product
Table 139. Actiza Pharmaceutical Recent Developments/Updates
Table 140. Teva Corporation Information
Table 141. Teva Description and Business Overview
Table 142. Teva Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Teva Gefitinib Tablets Product
Table 144. Teva Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Gefitinib Tablets Distributors List
Table 148. Gefitinib Tablets Customers List
Table 149. Gefitinib Tablets Market Trends
Table 150. Gefitinib Tablets Market Drivers
Table 151. Gefitinib Tablets Market Challenges
Table 152. Gefitinib Tablets Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gefitinib Tablets
Figure 2. Global Gefitinib Tablets Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Gefitinib Tablets Market Share by Type in 2022 & 2034
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Gefitinib Tablets Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Gefitinib Tablets Market Share by Application in 2022 & 2034
Figure 8. Breast Cancer
Figure 9. Lung Cancer
Figure 10. Other
Figure 11. Global Gefitinib Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Gefitinib Tablets Market Size (2018-2034) & (US$ Million)
Figure 13. Global Gefitinib Tablets Sales (2018-2034) & (K Units)
Figure 14. Global Gefitinib Tablets Average Price (US$/Unit) & (2018-2034)
Figure 15. Gefitinib Tablets Report Years Considered
Figure 16. Gefitinib Tablets Sales Share by Manufacturers in 2022
Figure 17. Global Gefitinib Tablets Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Gefitinib Tablets Players: Market Share by Revenue in 2022
Figure 19. Gefitinib Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Gefitinib Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Gefitinib Tablets Sales Market Share by Country (2018-2034)
Figure 22. North America Gefitinib Tablets Revenue Market Share by Country (2018-2034)
Figure 23. United States Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Gefitinib Tablets Sales Market Share by Country (2018-2034)
Figure 26. Europe Gefitinib Tablets Revenue Market Share by Country (2018-2034)
Figure 27. Germany Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Gefitinib Tablets Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Gefitinib Tablets Revenue Market Share by Region (2018-2034)
Figure 34. China Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Southeast Asia Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Latin America Gefitinib Tablets Sales Market Share by Country (2018-2034)
Figure 42. Latin America Gefitinib Tablets Revenue Market Share by Country (2018-2034)
Figure 43. Mexico Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Brazil Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Argentina Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Colombia Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Gefitinib Tablets Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Gefitinib Tablets Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Gefitinib Tablets Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Gefitinib Tablets by Type (2018-2034)
Figure 53. Global Revenue Market Share of Gefitinib Tablets by Type (2018-2034)
Figure 54. Global Gefitinib Tablets Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of Gefitinib Tablets by Application (2018-2034)
Figure 56. Global Revenue Market Share of Gefitinib Tablets by Application (2018-2034)
Figure 57. Global Gefitinib Tablets Price (US$/Unit) by Application (2018-2034)
Figure 58. Gefitinib Tablets Value Chain
Figure 59. Gefitinib Tablets Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed